| Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors BA Konkle, LS Ebbesen, E Erhardtsen, RP Bianco, T Lissitchkov, L Rusen, ... Journal of Thrombosis and Haemostasis 5 (9), 1904-1913, 2007 | 402 | 2007 |
| MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study R Pötter, K Tanderup, MP Schmid, I Jürgenliemk-Schulz, C Haie-Meder, ... The Lancet Oncology 22 (4), 538-547, 2021 | 332 | 2021 |
| Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors C Leissinger, A Gringeri, B Antmen, E Berntorp, C Biasoli, S Carpenter, ... New England Journal of Medicine 365 (18), 1684-1692, 2011 | 262 | 2011 |
| Inhibitors: resolving diagnostic and therapeutic dilemmas D Dimichele Haemophilia 8 (3), 280-287, 2002 | 209 | 2002 |
| Primary immunodeficiency diseases: an update IUIS PID CLASSIFICATION COMMITTEE CHAPEL H helen. chapel@ ndm. ox. ac. uk ... Clinical & Experimental Immunology 132 (1), 9-15, 2003 | 199 | 2003 |
| Long‐term FEIBA prophylaxis does not prevent progression of existing joint disease MW Hilgartner, A Makipernaa, DM Dimichele Haemophilia 9 (3), 261-268, 2003 | 100 | 2003 |
| Prophylaxis vs. on‐demand treatment with BAY 81‐8973, a full‐length plasma protein‐free recombinant factor VIII product: results from a randomized trial (LEOPOLD II) K Kavakli, R Yang, L Rusen, H Beckmann, D Tseneklidou‐Stoeter, ... Journal of Thrombosis and Haemostasis 13 (3), 360-369, 2015 | 95 | 2015 |
| Prophylactic treatment with activated prothrombin complex concentrate (FEIBA®) reduces the frequency of bleeding episodes in paediatric patients with … CA Leissinger, DL Becton, NP Ewing, LA Valentino Haemophilia 13 (3), 249-255, 2007 | 90 | 2007 |
| Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study B Tóth, A Volokha, A Mihas, M Pac, E Bernatowska, I Kondratenko, ... Molecular immunology 46 (10), 2140-2146, 2009 | 70 | 2009 |
| Haemophilia care in Europe: the ESCHQoL study W Schramm, A Gringeri, R Ljung, K Berger, A Crispin, M Bullinger, ... Haemophilia 18 (5), 729-737, 2012 | 63 | 2012 |
| PK‐guided personalized prophylaxis with Nuwiq® (human‐cl rhFVIII) in adults with severe haemophilia A T Lissitchkov, L Rusen, P Georgiev, J Windyga, R Klamroth, L Gercheva, ... Haemophilia 23 (5), 697-704, 2017 | 58 | 2017 |
| Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity JN Mahlangu, KN Weldingh, SR Lentz, S Kaicker, FA Karim, T Matsushita, ... Journal of thrombosis and haemostasis 13 (11), 1989-1998, 2015 | 55 | 2015 |
| Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency M Borte, M Pac, M Serban, T Gonzalez-Quevedo, B Grimbacher, S Jolles, ... Journal of clinical immunology 31, 752-761, 2011 | 54 | 2011 |
| Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with … J Windyga, T Lissitchkov, O Stasyshyn, V Mamonov, L Rusen, JL Lamas, ... Haemophilia 20 (1), 15-24, 2014 | 51 | 2014 |
| Molecular biology and clinical manifestation of hereditary factor VII deficiency FH Herrmann, K Wulff, K Auberger, V Aumann, F Bergmann, K Bergmann, ... Seminars in thrombosis and hemostasis 26 (04), 0393-0400, 2000 | 49 | 2000 |
| New clinical application of amniotic membrane transplant for ocular surface disease A Gheorghe, M Pop, M Burcea, M Serban Journal of medicine and life 9 (2), 177, 2016 | 47 | 2016 |
| A contiguous deletion syndrome of X‐linked agammaglobulinemia and sensorineural deafness D Richter, ME Conley, J Rohrer, LA Myers, K Zahradka, J Keleč Ić, J Sertić, ... Pediatric allergy and immunology 12 (2), 107-111, 2001 | 46 | 2001 |
| Surgical excision of a giant pelvic pseudotumour in a patient with haemophilia A LA Valentino, U Martinowitz, A Doolas, P Murali Haemophilia 12 (5), 541-544, 2006 | 40 | 2006 |
| BAY 81‐8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial R Ljung, G Kenet, ME Mancuso, V Kaleva, L Rusen, ... Haemophilia 22 (3), 354-360, 2016 | 36 | 2016 |
| Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glyco PEG ylated factor IX MA Escobar, R Tehranchi, FA Karim, U Caliskan, P Chowdary, T Colberg, ... Haemophilia 23 (1), 67-76, 2017 | 34 | 2017 |
